Literature DB >> 32157686

Antenatal models of care for women with gestational diabetes mellitus: Vignettes from an international meeting.

Maryam Sina1, Thomas J Cade2, Jeff Flack3, Christopher J Nolan4, Rohit Rajagopal5, Vincent Wong6, Linda Burcher7, Alison Barry8, Emily Gianatti9, Ana McCarthy10, Catharine McNamara11, Marina Mickelson12, Ruth Hughes13, Tara Jones14, Cathy Latino9, David McIntyre8, Sarah Price15, David Simmons1,5.   

Abstract

BACKGROUND: Gestational diabetes (GDM) is one of the commonest pregnancy complications and is placing an increasing burden on diabetes and obstetric resources. AIMS: To describe different antenatal models of care that have developed to address the increasing proportion of pregnancies complicated by GDM.
MATERIALS AND METHODS: Narrative review with thematic analysis from 15 volunteer antenatal diabetes in pregnancy services from Australia and New Zealand identified through a national diabetes organisation. Main outcomes were approaches to patient education, medical nutrition therapy (MNT), ongoing management and escalation of therapy for women with GDM.
RESULTS: All clinics provided at least one group education and one MNT session within 1-2 weeks of GDM diagnosis. Women from culturally and linguistically diverse communities usually required 1:1 education. Ongoing management of women with GDM was through either all women being seen in the GDM clinic, a step-up approach (ongoing management by the primary antenatal team with diabetes team referral if self-blood glucose monitoring (SBGM) or insulin therapy dosage criteria are reached) or step-down approach (ongoing management by the diabetes team with step-down to the primary antenatal team if SBGM criteria are reached). Telehealth was used to reduce the burden of clinic attendance, particularly in rural areas.
CONCLUSIONS: Increasing numbers, earlier diagnoses, the need to provide care to women in rural, remote areas, and cultural/language differences, have generated a range of different antenatal models of care, allowed better workload accommodation and probably reduced costs. Randomised controlled trials of different models of care, with associated health economic analyses, are urgently needed.
© 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  blood glucose self-monitoring; diabetes; gestational; glycated haemoglobin A; health care; interdisciplinary communication; nutritionists; process assessment; telemedicine

Mesh:

Substances:

Year:  2020        PMID: 32157686     DOI: 10.1111/ajo.13144

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  4 in total

Review 1.  Rural healthcare delivery and maternal and infant outcomes for diabetes in pregnancy: A systematic review.

Authors:  Ellen Payne; Gwendolyn Palmer; Megan Rollo; Kate Ryan; Sandra Harrison; Clare Collins; Katie Wynne; Leanne J Brown; Tracy Schumacher
Journal:  Nutr Diet       Date:  2022-02-06       Impact factor: 2.859

2.  The Perspectives of Diabetes Educators and Dietitians on Diet and Lifestyle Management for Gestational Diabetes Mellitus: A Qualitative Study.

Authors:  Amber J Hanks; Clare Hume; Siew Lim; Jessica A Grieger
Journal:  J Diabetes Res       Date:  2022-06-22       Impact factor: 4.061

3.  Pregnancy outcomes in women with gestational diabetes mellitus by models of care: a retrospective cohort study.

Authors:  Jackson Harrison; Sarah Melov; Adrienne C Kirby; Neil Athayde; Araz Boghossian; Wah Cheung; Emma Inglis; Kavita Maravar; Suja Padmanabhan; Melissa Luig; Monica Hook; Dharmintra Pasupathy
Journal:  BMJ Open       Date:  2022-09-26       Impact factor: 3.006

4.  The ADIPS Pilot National Diabetes in Pregnancy Benchmarking Programme.

Authors:  Jincy Immanuel; Jeff Flack; Vincent W Wong; Lili Yuen; Carl Eagleton; Dorothy Graham; Janet Lagstrom; Louise Wolmarans; Michele Martin; Ngai Wah Cheung; Suja Padmanabhan; Victoria Rudland; Glynis Ross; Robert G Moses; Louise Maple-Brown; Ian Fulcher; Julie Chemmanam; Christopher J Nolan; Jeremy J N Oats; Arianne Sweeting; David Simmons
Journal:  Int J Environ Res Public Health       Date:  2021-05-04       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.